IPOGridAI Technologies Amends S-1 as Energy-AI Pivot ContinuesGridAI Technologies, formerly biopharma company Entero Therapeutics, filed an amended S-1 registering shares tied to recent PIPE financings as it repositions around energy-orchestration and grid-optimization software for AI datacenters.Jul 9, 2026